Toward a Learning Health-Care System: Use of Colorectal Cancer Quality Measures for Physician Evaluation


Goal

Description

Agile

Cycle time for measurement development to implementation should be short to maximize adaptability to new evidence

Broad-based

Must address priority domains of the national quality strategy (e.g., clinical care, patient experience, population health, safety, care coordination, and cost/efficiency)

Feasible

Must minimize the burden for data collection and reporting

Impactful

Prioritize outcome measures over process measures

Support feedback

Should enable provider feedback through decision-support tools

Vertically aligned

Should capture quality information at the level of the clinician, provider group, and population



Common to these frameworks is the importance of developing actionable measures for performance improvement. Action can take a number of forms, including performance feedback, pay for performance , public reporting, and physician designation . Each of these will be discussed separately below.


Performance Feedback


There are a number of theories as to how performance feedback can improve the quality of health-care practice. These include changing awareness about current practices, changing social norms, enabling self-efficacy, and facilitating goal setting [9]. The evidence suggests that “audit and feedback” approaches generally result in improvement in practice, and the degree of improvement depends on an individual’s performance at baseline and the type of feedback provided [9]. For example, feedback has been shown to be more effective when it is provided by a supervisor or a colleague, when it is provided more than once, when it is provided in both verbal and written form, and when it provides unambiguous targets for action.

At the population level, the rate of CRC screening uptake is a key measure used in performance feedback systems. Studies have shown that assessment and feedback of provider performance in CRC screening leads to improved performance [10, 11]. As it relates to colonoscopy quality, a number of studies have examined the impact of performance feedback on quality measures, and the majority have shown no impact on polyp detection rates [12]. However, three studies deserve mention. The first described an intervention that combined audible withdrawal timer with improved inspection technique [13]. This feedback intervention resulted in a significant increase in the detection of polyps as well as an overall population-level increase in the detection of advanced adenomas. In a recent study in the Veterans Health Administration, a quarterly report card resulted in a significant increase in adenoma detection and cecal intubation rates [14]. In a third study, an educational intervention combined with monthly feedback of adenoma detection rates resulted in marked improvement in detection rates during the course of the intervention [15]. Of note, none of these studies found a significant increase in advanced adenoma detection among physicians. More importantly, none have been able to assess the impact on the truly meaningful outcome, namely CRC incidence.


Pay for Performance


Tying financial incentives to performance feedback is one potential mechanism to augment the impact of physician feedback programs . Pay-for-performance (P4P) programs are in place for traditional Medicare inpatient and Medicare advantage plans, where withholds for nonparticipation will be implemented for individual physicians beginning in 2015. The individual physician program is based on the physician quality reporting system (PQRS) which has been in place since 2007 [16]. The physician value-based payment modifier (VBPM) will initially encourage participation but will quickly expand to incentivize performance on a defined set of measures [17].

Evidence on the impact of P4P programs is mixed [16]. Robust assessments of the impact of these interventions are lacking, and it is difficult to draw definitive conclusions from the existing literature [18]. The lack of impact of P4P programs may be related to inadequate incentive size, incentive structures, and even the choice of metrics themselves [19].

Dedicated studies evaluating the impact of P4P in CRC screening are not available although the American College of Gastroenterology (ACG) has identified a set of principles for the development and evaluation of these programs [20]. Furthermore, others have outlined recommendations for the use of payment reform to improve colonoscopy quality [21]. Several CRC screening quality measures are included in the government’s P4P program and will be further described below .


Public Reporting


The belief that public reporting will result in improved quality is based on the notion that, in a competitive marketplace, information disclosure will cause self-regulation of the health-care system through actions on purchasers, consumers, policymakers, providers, and the public [22]. There are success stories in the general medical literature [23, 24], but the quality of the data is insufficient to make any broad conclusions on the impact of public reporting on consumer behavior, provider behavior, or clinical outcomes in health care [25, 26]. Furthermore, physicians are wary of public reporting programs because of concerns that these programs will distract the public from paying attention to the unmeasured components of health-care quality and will cause providers to avoid high-risk patients or perhaps even lower the quality of care through unintended consequences [27, 28].

In CRC screening, there are a few studies examining the impact of public reporting on the quality of care. Sarfaty and Myers found that the addition of a CRC screening rate to the HEDIS measures resulted in a number of changes by Pennsylvania health plans to increase screening rates in their populations [29]. This is notable because very few health plans had comprehensive management of CRC screening programs before that time [30]. The impact of public reporting of other quality measures in CRC screening is yet to be determined as many of these measures are still in their developmental stages.


Physician Designation


One particular method of public reporting is the use of “physician designation” programs. These are programs that rate, rank, or tier health-care providers based on measures of quality and cost with the hopes of directing patients to the preferred providers . One of the earliest attempts at physician designation was the creation of preferred provider organizations (PPO), where physicians were either in or out of the network [31]. These networks surged in popularity in the late 1990s to early 2000s and remain as the predominant option for commercial payers, but have failed to deliver substantive cost or quality improvements [32].

More recent attempts at physician designation have relied on more sophisticated criteria of quality and cost, balancing performance feedback with elements of public reporting. Key to the success of these programs is the accuracy of information provided to the public, and accuracy has been one of the concerns prompting legal action around physician designation. One early example is action taken by the Attorney General of New York in 2007 [33]. In response to attempts by insurers to tier physicians on quality and cost-efficiency, the NY Attorney General initiated an investigation that lead to a wide-reaching agreement with a number of insurers to create a core set of principles for the accuracy and transparency of data used for physician tiering .

In 2008, Colorado enacted legislation-requiring standards and procedures for health insurers that are initiating physician-rating systems [31]. The Physician Designation Disclosure Act has a number of key requirements: first, the law requires that any public reporting or ranking of a physician’s performance must include quality of care data; second, performance measures used in the ranking must be endorsed by the National Quality Forum , a national physician-specialty group or the Colorado Clinical Guidelines Collaborative and be measured in a statistically sound fashion; third, the rating must include a disclaimer advising patients not to rely solely on the ranking in choosing a physician; finally, the law gives physicians right to review the data on which his/her ranking is based and to take action should they feel the data misrepresent their practice. Similar legislation has been considered in a number of other states, including Oklahoma, Maryland, and Texas .

The impact of these programs on quality and cost of CRC screening remains unknown. In part, it is unclear to what extent differentiation of providers using existing performance metrics will impact the quality of care. Furthermore, physician cost profiling has been shown to be unreliable [34], and it remains to be seen how cost transparency will influence patient and physician behavior .



Existing Evaluation Systems


Using performance feedback, P4P, public reporting, and physician designation as the levers of action, a number of entities in the USA use CRC screening quality measures for physician evaluation. In this section, we will review a number of these programs with a specific focus on government, commercial, and regional programs as well as those of integrated delivery systems.


Government


As discussed above, the PQRS is a P4P program that has been the primary government-level evaluation program geared toward physicians. In 2011, Centers for Medicare & Medicaid Services (CMS) paid more than US$ 261 million to 26,515 practices, which included 266,521 providers [35]. Included in this amount were 2370 gastroenterologists who participated in the program, representing 26.1 % of the eligible professionals. This number is quite small when compared to the 41,998 internists and family practice physicians who participated in the program in 2011. However, it represents a significant increase since only 8.1 % of the eligible gastroenterologists participated in 2008.

The tenth most commonly individual reported measure in the PQRS system among all providers was the CRC screening (Measure #113) measure. For gastroenterologists, the most commonly reported individual measures are listed in Table 8.2. PQRS measures around CRC screening for the 2013 reporting year are listed in Table 8.3. Screening colonoscopy adenoma detection rate (ADR) has been proposed by CMS for incorporation in the performance year 2014 and several new measures have been proposed by the gastrointestinal (GI) societies for 2015, including: repeat colonoscopy due to poor bowel preparation, and appropriate age for CRC screening [36].


Table 8.2
Most commonly reported physician quality reporting system (PQRS) measures among gastroenterologists 2011
































Rank #

Measure #

Description

1

124

Health information technology: adoption/use of electronic health records (EHR)

2

113

Preventive care and screening—colorectal cancer (CRC) screening

3

130

Documentation of current medications in the medical record

4

226

Tobacco use: screening and cessation intervention

5

185

Endoscopy and polyp surveillance: colonoscopy interval for patients with history of adenomatous polyps—avoidance of inappropriate use



Table 8.3
2013 physician quality reporting system (PQRS) measures related to colorectal cancer (CRC) screening




























Measure #

National quality strategy domain

Description

113

Clinical process/effectiveness

Preventive care and screening—colorectal cancer screening (percentage of patients aged 50 through 75 years who received the appropriate colorectal cancer screening)

185

Care coordination

Endoscopy and polyp surveillance: colonoscopy interval for patients with history of adenomatous polyps—avoidance of inappropriate use (percentage of patients aged 18 years and older receiving a surveillance colonoscopy with a history of a prior colonic polyp(s) in previous colonoscopy findings, who had an interval of 3 or more years since their last colonoscopy)

320

Care coordination

Endoscopy/polyp surveillance: appropriate follow-up interval for normal colonoscopy in average risk patients (percentage of patients aged 50 years and older receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report)

321

Care coordination

Participation in a systematic clinical database registry that includes consensus endorsed quality (participation in a systematic qualified clinical database registry)

To date, all current CRC quality measures (CRC screening rates, ADR detection rates, surveillance intervals after normal screening, and after adenomatous polyps) are process measures. Questions have arisen as to whether the existing CRC quality measures are satisfactory, or should be revised in view of updated recommendations from the special societies regarding surveillance intervals after polypectomy [37] as evidenced by the National Quality Forum’s August 2013 decision to not endorse measure 0659 (Endoscopy/polyp surveillance: colonoscopy interval for patients with a history of adenomatous polyps—avoidance of inappropriate use) [38].

The lack of outcome measures for gastroenterology has been cited as a concern with the existing measures. In response, CMS has contracted with Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation (CORE) to develop administrative claims-based, risk-adjusted measures of high-acuity care visits after an outpatient colonoscopy or endoscopy procedure. High-acuity care visits are defined as inpatient admissions, observation stays, or emergency department visits, and may represent complications due to outpatient procedures [39]. A technical expert panel was convened in 2013, with the objective of developing measures by 2014 that can be used to measure and improve the quality of care provided to Medicare beneficiaries, and to potentially submit these measures to the National Quality Forum for endorsement.

In addition to process measures of quality, government programs have begun to transition to value-based incentive programs. As gastrointestinal endoscopic procedures as a whole make up the largest percentage (32.7 %) of ambulatory surgical center (ASC) claims in Medicare, gastroenterologists will have a key stake in this process through the development of Medicare’s value-based purchasing program for ASCs. The American Society for Gastrointestinal Endoscopy (ASGE) proposed three gastroenterology-specific measures for this program: (1) Appropriate follow-up interval for normal colonoscopy in average risk patients, (2) colonoscopy interval for patients with a history of adenomatous polyps—avoidance of inappropriate use, and (3) comprehensive colonoscopy documentation [40].


Commercial


As with government programs, commercial entities are focusing on value over cost or quality alone. Most commercial programs use physician designation programs based on physician quality and cost to evaluate physicians and incentivize patient behavior. A sample of these programs is represented in Table 8.4. All of the programs reviewed, start with quality designation and augment designation based on cost. These programs use proprietary software to group claim data into episodes of care when considering cost. The criteria for meeting quality and cost designations vary among programs and several entities rely on commercial vendors with proprietary ranking technology to calculate claim-based measures.


Table 8.4
Commercial physician designation programs














































Program

Description

Include GI

Peer group

Case-mix adjusted

Quality of care

Cost efficiency

United Health Care Premium ® Designation [41]

Physicians or centers that earn designation are (1) identified in a directory and (2) considered for financial incentives

No

National for quality; physician specialty and geographic location for cost

Yes, for certain quality metrics and all costs

Claims-based; augmented by physician participation in BTE, NCQA, or ABIM programs

Percentile rankings of episode costs compared to peer group

Medica Premium Designation [42]

Physicians who receive the two-star designation cost average 10–20 % less for patients

No

National for quality; physician specialty and geographic location for cost

Yes, for certain quality metrics and all costs

Claims-based and/or practice data; measure physician performance over 39 months against evidence-based guidelines; must also be board-certified

Percentile rankings of episode costs compared to peer group

Aetna Aexcel ® Program [43]

Practices that receive the designation may be lower cost to insured depending on specific plan

Yes

Physicians of the same specialty in the same Aexcel market or market type if volume is low

Yes, for certain quality metrics and all costs

Specialists must meet at least one of the five criteria for quality: (1) use of technology, (2) alignment with Aetna Institute of Quality, (3) certification from external entity (BTE, NCQA), (4) Board certification, or (5) claim-based measures

Percentile rankings of episode costs compared to peer group

BlueCross BlueShield of North Carolina Tiered Provider Network [46]

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 31, 2017 | Posted by in ONCOLOGY | Comments Off on Toward a Learning Health-Care System: Use of Colorectal Cancer Quality Measures for Physician Evaluation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access